nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—SLCO1B1—Irinotecan—lung cancer	0.0277	0.535	CbGbCtD
Acetylcysteine—SLCO1B1—Methotrexate—lung cancer	0.0146	0.283	CbGbCtD
Acetylcysteine—SLC22A6—Methotrexate—lung cancer	0.00941	0.182	CbGbCtD
Acetylcysteine—ACY1—respiratory system—lung cancer	0.00818	0.143	CbGeAlD
Acetylcysteine—L-Cysteine—GCLC—lung cancer	0.00588	1	CrCbGaD
Acetylcysteine—CHUK—epithelium—lung cancer	0.00472	0.0825	CbGeAlD
Acetylcysteine—ACY1—lung—lung cancer	0.00434	0.0759	CbGeAlD
Acetylcysteine—SLCO1B1—mammary gland—lung cancer	0.00416	0.0727	CbGeAlD
Acetylcysteine—IKBKB—respiratory system—lung cancer	0.00384	0.0671	CbGeAlD
Acetylcysteine—GSS—respiratory system—lung cancer	0.00377	0.0659	CbGeAlD
Acetylcysteine—IKBKB—bronchus—lung cancer	0.00316	0.0552	CbGeAlD
Acetylcysteine—GSS—bronchus—lung cancer	0.0031	0.0542	CbGeAlD
Acetylcysteine—CHUK—lung—lung cancer	0.003	0.0524	CbGeAlD
Acetylcysteine—GSS—trachea—lung cancer	0.00278	0.0487	CbGeAlD
Acetylcysteine—GSS—cardiac atrium—lung cancer	0.00262	0.0457	CbGeAlD
Acetylcysteine—SLC7A11—lung—lung cancer	0.00247	0.0432	CbGeAlD
Acetylcysteine—GSS—bone marrow—lung cancer	0.00221	0.0386	CbGeAlD
Acetylcysteine—CHUK—lymph node—lung cancer	0.00205	0.0359	CbGeAlD
Acetylcysteine—IKBKB—lung—lung cancer	0.00204	0.0356	CbGeAlD
Acetylcysteine—GSS—lung—lung cancer	0.002	0.035	CbGeAlD
Acetylcysteine—IKBKB—lymph node—lung cancer	0.00139	0.0244	CbGeAlD
Acetylcysteine—GSS—lymph node—lung cancer	0.00137	0.0239	CbGeAlD
Acetylcysteine—Dermatitis—Teniposide—lung cancer	0.000741	0.00221	CcSEcCtD
Acetylcysteine—Bronchospasm—Docetaxel—lung cancer	0.000736	0.00219	CcSEcCtD
Acetylcysteine—Erythema—Gemcitabine—lung cancer	0.000734	0.00219	CcSEcCtD
Acetylcysteine—Flushing—Cisplatin—lung cancer	0.00073	0.00217	CcSEcCtD
Acetylcysteine—Cardiac disorder—Cisplatin—lung cancer	0.00073	0.00217	CcSEcCtD
Acetylcysteine—Tachycardia—Vinorelbine—lung cancer	0.000728	0.00217	CcSEcCtD
Acetylcysteine—Skin disorder—Vinorelbine—lung cancer	0.000725	0.00216	CcSEcCtD
Acetylcysteine—Immune system disorder—Cisplatin—lung cancer	0.00071	0.00211	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Cisplatin—lung cancer	0.000709	0.00211	CcSEcCtD
Acetylcysteine—Pharyngitis—Paclitaxel—lung cancer	0.000701	0.00209	CcSEcCtD
Acetylcysteine—Nausea—Teniposide—lung cancer	0.000699	0.00208	CcSEcCtD
Acetylcysteine—Hypotension—Vinorelbine—lung cancer	0.000697	0.00207	CcSEcCtD
Acetylcysteine—Urticaria—Topotecan—lung cancer	0.000693	0.00206	CcSEcCtD
Acetylcysteine—Body temperature increased—Topotecan—lung cancer	0.000689	0.00205	CcSEcCtD
Acetylcysteine—Erythema—Cisplatin—lung cancer	0.000684	0.00204	CcSEcCtD
Acetylcysteine—Body temperature increased—Erlotinib—lung cancer	0.000682	0.00203	CcSEcCtD
Acetylcysteine—Syncope—Irinotecan—lung cancer	0.000676	0.00201	CcSEcCtD
Acetylcysteine—Cardiac disorder—Etoposide—lung cancer	0.000669	0.00199	CcSEcCtD
Acetylcysteine—Flushing—Etoposide—lung cancer	0.000669	0.00199	CcSEcCtD
Acetylcysteine—Dyspnoea—Vinorelbine—lung cancer	0.000665	0.00198	CcSEcCtD
Acetylcysteine—Loss of consciousness—Irinotecan—lung cancer	0.000663	0.00197	CcSEcCtD
Acetylcysteine—Hypersensitivity—Vinblastine—lung cancer	0.000661	0.00197	CcSEcCtD
Acetylcysteine—Cough—Irinotecan—lung cancer	0.000658	0.00196	CcSEcCtD
Acetylcysteine—Cardiac disorder—Paclitaxel—lung cancer	0.000656	0.00195	CcSEcCtD
Acetylcysteine—Flushing—Paclitaxel—lung cancer	0.000656	0.00195	CcSEcCtD
Acetylcysteine—Angiopathy—Etoposide—lung cancer	0.000654	0.00195	CcSEcCtD
Acetylcysteine—Immune system disorder—Etoposide—lung cancer	0.000651	0.00194	CcSEcCtD
Acetylcysteine—Stomatitis—Docetaxel—lung cancer	0.00065	0.00193	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Etoposide—lung cancer	0.000649	0.00193	CcSEcCtD
Acetylcysteine—Mental disability—Doxorubicin—lung cancer	0.000646	0.00192	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Methotrexate—lung cancer	0.000644	0.00192	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000644	0.00192	CcSEcCtD
Acetylcysteine—Hypersensitivity—Topotecan—lung cancer	0.000643	0.00191	CcSEcCtD
Acetylcysteine—Cough—Gemcitabine—lung cancer	0.000641	0.00191	CcSEcCtD
Acetylcysteine—Angiopathy—Paclitaxel—lung cancer	0.000641	0.00191	CcSEcCtD
Acetylcysteine—Immune system disorder—Paclitaxel—lung cancer	0.000638	0.0019	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Paclitaxel—lung cancer	0.000637	0.00189	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000621	0.00185	CcSEcCtD
Acetylcysteine—Pruritus—Topotecan—lung cancer	0.000617	0.00184	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Irinotecan—lung cancer	0.000615	0.00183	CcSEcCtD
Acetylcysteine—Oedema—Irinotecan—lung cancer	0.000615	0.00183	CcSEcCtD
Acetylcysteine—Erythema—Paclitaxel—lung cancer	0.000615	0.00183	CcSEcCtD
Acetylcysteine—Pruritus—Erlotinib—lung cancer	0.00061	0.00182	CcSEcCtD
Acetylcysteine—Shock—Irinotecan—lung cancer	0.000605	0.0018	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Gemcitabine—lung cancer	0.000599	0.00178	CcSEcCtD
Acetylcysteine—Oedema—Gemcitabine—lung cancer	0.000599	0.00178	CcSEcCtD
Acetylcysteine—Eye pain—Doxorubicin—lung cancer	0.000598	0.00178	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Irinotecan—lung cancer	0.000595	0.00177	CcSEcCtD
Acetylcysteine—Pharyngitis—Docetaxel—lung cancer	0.000594	0.00177	CcSEcCtD
Acetylcysteine—Dizziness—Vinblastine—lung cancer	0.000594	0.00177	CcSEcCtD
Acetylcysteine—Urticaria—Vinorelbine—lung cancer	0.000593	0.00176	CcSEcCtD
Acetylcysteine—Body temperature increased—Vinorelbine—lung cancer	0.00059	0.00176	CcSEcCtD
Acetylcysteine—Skin disorder—Gemcitabine—lung cancer	0.000582	0.00173	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Gemcitabine—lung cancer	0.000579	0.00172	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000579	0.00172	CcSEcCtD
Acetylcysteine—Dizziness—Topotecan—lung cancer	0.000577	0.00172	CcSEcCtD
Acetylcysteine—Hypotension—Irinotecan—lung cancer	0.000575	0.00171	CcSEcCtD
Acetylcysteine—Vomiting—Vinblastine—lung cancer	0.000571	0.0017	CcSEcCtD
Acetylcysteine—Dizziness—Erlotinib—lung cancer	0.000571	0.0017	CcSEcCtD
Acetylcysteine—Angioedema—Paclitaxel—lung cancer	0.000562	0.00167	CcSEcCtD
Acetylcysteine—Hypotension—Gemcitabine—lung cancer	0.00056	0.00167	CcSEcCtD
Acetylcysteine—Oedema—Cisplatin—lung cancer	0.000559	0.00166	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Cisplatin—lung cancer	0.000559	0.00166	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Doxorubicin—lung cancer	0.000558	0.00166	CcSEcCtD
Acetylcysteine—Cardiac disorder—Docetaxel—lung cancer	0.000556	0.00165	CcSEcCtD
Acetylcysteine—Flushing—Docetaxel—lung cancer	0.000556	0.00165	CcSEcCtD
Acetylcysteine—Vomiting—Topotecan—lung cancer	0.000555	0.00165	CcSEcCtD
Acetylcysteine—Syncope—Paclitaxel—lung cancer	0.000551	0.00164	CcSEcCtD
Acetylcysteine—Loss of consciousness—Etoposide—lung cancer	0.000551	0.00164	CcSEcCtD
Acetylcysteine—Rash—Topotecan—lung cancer	0.00055	0.00164	CcSEcCtD
Acetylcysteine—Hypersensitivity—Vinorelbine—lung cancer	0.00055	0.00164	CcSEcCtD
Acetylcysteine—Dermatitis—Topotecan—lung cancer	0.000549	0.00164	CcSEcCtD
Acetylcysteine—Vomiting—Erlotinib—lung cancer	0.000549	0.00163	CcSEcCtD
Acetylcysteine—Dyspnoea—Irinotecan—lung cancer	0.000549	0.00163	CcSEcCtD
Acetylcysteine—Cough—Etoposide—lung cancer	0.000547	0.00163	CcSEcCtD
Acetylcysteine—Somnolence—Irinotecan—lung cancer	0.000547	0.00163	CcSEcCtD
Acetylcysteine—Tachycardia—Cisplatin—lung cancer	0.000545	0.00162	CcSEcCtD
Acetylcysteine—Rash—Erlotinib—lung cancer	0.000544	0.00162	CcSEcCtD
Acetylcysteine—Dermatitis—Erlotinib—lung cancer	0.000544	0.00162	CcSEcCtD
Acetylcysteine—Angiopathy—Docetaxel—lung cancer	0.000543	0.00162	CcSEcCtD
Acetylcysteine—Skin disorder—Cisplatin—lung cancer	0.000543	0.00162	CcSEcCtD
Acetylcysteine—Dyspepsia—Irinotecan—lung cancer	0.000542	0.00161	CcSEcCtD
Acetylcysteine—Immune system disorder—Docetaxel—lung cancer	0.000541	0.00161	CcSEcCtD
Acetylcysteine—Loss of consciousness—Paclitaxel—lung cancer	0.00054	0.00161	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Cisplatin—lung cancer	0.00054	0.00161	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Docetaxel—lung cancer	0.00054	0.00161	CcSEcCtD
Acetylcysteine—Asthma—Methotrexate—lung cancer	0.000539	0.0016	CcSEcCtD
Acetylcysteine—Cough—Paclitaxel—lung cancer	0.000537	0.0016	CcSEcCtD
Acetylcysteine—Dyspnoea—Gemcitabine—lung cancer	0.000534	0.00159	CcSEcCtD
Acetylcysteine—Nausea—Vinblastine—lung cancer	0.000533	0.00159	CcSEcCtD
Acetylcysteine—Somnolence—Gemcitabine—lung cancer	0.000533	0.00159	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Irinotecan—lung cancer	0.000531	0.00158	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.00053	0.00158	CcSEcCtD
Acetylcysteine—Pruritus—Vinorelbine—lung cancer	0.000528	0.00157	CcSEcCtD
Acetylcysteine—Hypotension—Cisplatin—lung cancer	0.000522	0.00155	CcSEcCtD
Acetylcysteine—Face oedema—Doxorubicin—lung cancer	0.000521	0.00155	CcSEcCtD
Acetylcysteine—Erythema—Docetaxel—lung cancer	0.000521	0.00155	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.00052	0.00155	CcSEcCtD
Acetylcysteine—Nausea—Topotecan—lung cancer	0.000518	0.00154	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000517	0.00154	CcSEcCtD
Acetylcysteine—Nausea—Erlotinib—lung cancer	0.000513	0.00153	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Etoposide—lung cancer	0.000512	0.00152	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Paclitaxel—lung cancer	0.000502	0.00149	CcSEcCtD
Acetylcysteine—Oedema—Paclitaxel—lung cancer	0.000502	0.00149	CcSEcCtD
Acetylcysteine—Tachycardia—Etoposide—lung cancer	0.000499	0.00149	CcSEcCtD
Acetylcysteine—Dyspnoea—Cisplatin—lung cancer	0.000498	0.00148	CcSEcCtD
Acetylcysteine—Skin disorder—Etoposide—lung cancer	0.000497	0.00148	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Etoposide—lung cancer	0.000495	0.00147	CcSEcCtD
Acetylcysteine—Shock—Paclitaxel—lung cancer	0.000494	0.00147	CcSEcCtD
Acetylcysteine—Dizziness—Vinorelbine—lung cancer	0.000493	0.00147	CcSEcCtD
Acetylcysteine—Tachycardia—Paclitaxel—lung cancer	0.00049	0.00146	CcSEcCtD
Acetylcysteine—Skin disorder—Paclitaxel—lung cancer	0.000487	0.00145	CcSEcCtD
Acetylcysteine—Body temperature increased—Irinotecan—lung cancer	0.000486	0.00145	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Paclitaxel—lung cancer	0.000485	0.00144	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Doxorubicin—lung cancer	0.000483	0.00144	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000482	0.00144	CcSEcCtD
Acetylcysteine—Drowsiness—Methotrexate—lung cancer	0.000481	0.00143	CcSEcCtD
Acetylcysteine—Hypotension—Etoposide—lung cancer	0.000478	0.00142	CcSEcCtD
Acetylcysteine—Vomiting—Vinorelbine—lung cancer	0.000474	0.00141	CcSEcCtD
Acetylcysteine—Body temperature increased—Gemcitabine—lung cancer	0.000474	0.00141	CcSEcCtD
Acetylcysteine—Rash—Vinorelbine—lung cancer	0.00047	0.0014	CcSEcCtD
Acetylcysteine—Dermatitis—Vinorelbine—lung cancer	0.00047	0.0014	CcSEcCtD
Acetylcysteine—Hypotension—Paclitaxel—lung cancer	0.000469	0.0014	CcSEcCtD
Acetylcysteine—Stomatitis—Methotrexate—lung cancer	0.000469	0.00139	CcSEcCtD
Acetylcysteine—Syncope—Docetaxel—lung cancer	0.000467	0.00139	CcSEcCtD
Acetylcysteine—Asthma—Doxorubicin—lung cancer	0.000467	0.00139	CcSEcCtD
Acetylcysteine—Sweating—Methotrexate—lung cancer	0.000461	0.00137	CcSEcCtD
Acetylcysteine—Loss of consciousness—Docetaxel—lung cancer	0.000458	0.00136	CcSEcCtD
Acetylcysteine—Dyspnoea—Etoposide—lung cancer	0.000456	0.00136	CcSEcCtD
Acetylcysteine—Somnolence—Etoposide—lung cancer	0.000455	0.00135	CcSEcCtD
Acetylcysteine—Cough—Docetaxel—lung cancer	0.000455	0.00135	CcSEcCtD
Acetylcysteine—Hypersensitivity—Irinotecan—lung cancer	0.000453	0.00135	CcSEcCtD
Acetylcysteine—Dyspnoea—Paclitaxel—lung cancer	0.000447	0.00133	CcSEcCtD
Acetylcysteine—Somnolence—Paclitaxel—lung cancer	0.000446	0.00133	CcSEcCtD
Acetylcysteine—Nausea—Vinorelbine—lung cancer	0.000443	0.00132	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Etoposide—lung cancer	0.000442	0.00132	CcSEcCtD
Acetylcysteine—Dyspepsia—Paclitaxel—lung cancer	0.000442	0.00131	CcSEcCtD
Acetylcysteine—Body temperature increased—Cisplatin—lung cancer	0.000442	0.00131	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000441	0.00131	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000433	0.00129	CcSEcCtD
Acetylcysteine—Pharyngitis—Methotrexate—lung cancer	0.000428	0.00127	CcSEcCtD
Acetylcysteine—Oedema—Docetaxel—lung cancer	0.000425	0.00127	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Docetaxel—lung cancer	0.000425	0.00127	CcSEcCtD
Acetylcysteine—Pruritus—Gemcitabine—lung cancer	0.000424	0.00126	CcSEcCtD
Acetylcysteine—Shock—Docetaxel—lung cancer	0.000418	0.00125	CcSEcCtD
Acetylcysteine—Drowsiness—Doxorubicin—lung cancer	0.000416	0.00124	CcSEcCtD
Acetylcysteine—Tachycardia—Docetaxel—lung cancer	0.000415	0.00124	CcSEcCtD
Acetylcysteine—Skin disorder—Docetaxel—lung cancer	0.000413	0.00123	CcSEcCtD
Acetylcysteine—Hypersensitivity—Cisplatin—lung cancer	0.000412	0.00123	CcSEcCtD
Acetylcysteine—Dizziness—Irinotecan—lung cancer	0.000407	0.00121	CcSEcCtD
Acetylcysteine—Urticaria—Etoposide—lung cancer	0.000407	0.00121	CcSEcCtD
Acetylcysteine—Stomatitis—Doxorubicin—lung cancer	0.000406	0.00121	CcSEcCtD
Acetylcysteine—Body temperature increased—Etoposide—lung cancer	0.000405	0.0012	CcSEcCtD
Acetylcysteine—Cardiac disorder—Methotrexate—lung cancer	0.0004	0.00119	CcSEcCtD
Acetylcysteine—Sweating—Doxorubicin—lung cancer	0.000399	0.00119	CcSEcCtD
Acetylcysteine—Urticaria—Paclitaxel—lung cancer	0.000399	0.00119	CcSEcCtD
Acetylcysteine—Hypotension—Docetaxel—lung cancer	0.000397	0.00118	CcSEcCtD
Acetylcysteine—Body temperature increased—Paclitaxel—lung cancer	0.000397	0.00118	CcSEcCtD
Acetylcysteine—Angiopathy—Methotrexate—lung cancer	0.000391	0.00117	CcSEcCtD
Acetylcysteine—Vomiting—Irinotecan—lung cancer	0.000391	0.00116	CcSEcCtD
Acetylcysteine—Immune system disorder—Methotrexate—lung cancer	0.00039	0.00116	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Methotrexate—lung cancer	0.000389	0.00116	CcSEcCtD
Acetylcysteine—Rash—Irinotecan—lung cancer	0.000388	0.00115	CcSEcCtD
Acetylcysteine—Dermatitis—Irinotecan—lung cancer	0.000388	0.00115	CcSEcCtD
Acetylcysteine—Vomiting—Gemcitabine—lung cancer	0.000381	0.00113	CcSEcCtD
Acetylcysteine—Dyspnoea—Docetaxel—lung cancer	0.000379	0.00113	CcSEcCtD
Acetylcysteine—Somnolence—Docetaxel—lung cancer	0.000378	0.00113	CcSEcCtD
Acetylcysteine—Rash—Gemcitabine—lung cancer	0.000378	0.00112	CcSEcCtD
Acetylcysteine—Dermatitis—Gemcitabine—lung cancer	0.000378	0.00112	CcSEcCtD
Acetylcysteine—Hypersensitivity—Etoposide—lung cancer	0.000377	0.00112	CcSEcCtD
Acetylcysteine—Erythema—Methotrexate—lung cancer	0.000376	0.00112	CcSEcCtD
Acetylcysteine—Dyspepsia—Docetaxel—lung cancer	0.000374	0.00111	CcSEcCtD
Acetylcysteine—Pharyngitis—Doxorubicin—lung cancer	0.000371	0.0011	CcSEcCtD
Acetylcysteine—Hypersensitivity—Paclitaxel—lung cancer	0.00037	0.0011	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Docetaxel—lung cancer	0.000367	0.00109	CcSEcCtD
Acetylcysteine—Nausea—Irinotecan—lung cancer	0.000365	0.00109	CcSEcCtD
Acetylcysteine—Pruritus—Etoposide—lung cancer	0.000362	0.00108	CcSEcCtD
Acetylcysteine—Nausea—Gemcitabine—lung cancer	0.000356	0.00106	CcSEcCtD
Acetylcysteine—Vomiting—Cisplatin—lung cancer	0.000355	0.00106	CcSEcCtD
Acetylcysteine—Pruritus—Paclitaxel—lung cancer	0.000355	0.00106	CcSEcCtD
Acetylcysteine—Rash—Cisplatin—lung cancer	0.000352	0.00105	CcSEcCtD
Acetylcysteine—Dermatitis—Cisplatin—lung cancer	0.000352	0.00105	CcSEcCtD
Acetylcysteine—Cardiac disorder—Doxorubicin—lung cancer	0.000347	0.00103	CcSEcCtD
Acetylcysteine—Flushing—Doxorubicin—lung cancer	0.000347	0.00103	CcSEcCtD
Acetylcysteine—Angiopathy—Doxorubicin—lung cancer	0.000339	0.00101	CcSEcCtD
Acetylcysteine—Dizziness—Etoposide—lung cancer	0.000338	0.00101	CcSEcCtD
Acetylcysteine—Immune system disorder—Doxorubicin—lung cancer	0.000337	0.001	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Doxorubicin—lung cancer	0.000337	0.001	CcSEcCtD
Acetylcysteine—Body temperature increased—Docetaxel—lung cancer	0.000336	0.001	CcSEcCtD
Acetylcysteine—Dizziness—Paclitaxel—lung cancer	0.000332	0.000988	CcSEcCtD
Acetylcysteine—Nausea—Cisplatin—lung cancer	0.000332	0.000988	CcSEcCtD
Acetylcysteine—Cough—Methotrexate—lung cancer	0.000328	0.000976	CcSEcCtD
Acetylcysteine—Vomiting—Etoposide—lung cancer	0.000325	0.000969	CcSEcCtD
Acetylcysteine—Erythema—Doxorubicin—lung cancer	0.000325	0.000968	CcSEcCtD
Acetylcysteine—Rash—Etoposide—lung cancer	0.000323	0.00096	CcSEcCtD
Acetylcysteine—Dermatitis—Etoposide—lung cancer	0.000322	0.00096	CcSEcCtD
Acetylcysteine—Vomiting—Paclitaxel—lung cancer	0.000319	0.00095	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000318	0.000945	CcSEcCtD
Acetylcysteine—Rash—Paclitaxel—lung cancer	0.000316	0.000942	CcSEcCtD
Acetylcysteine—Dermatitis—Paclitaxel—lung cancer	0.000316	0.000941	CcSEcCtD
Acetylcysteine—Hypersensitivity—Docetaxel—lung cancer	0.000313	0.000933	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Methotrexate—lung cancer	0.000307	0.000912	CcSEcCtD
Acetylcysteine—Nausea—Etoposide—lung cancer	0.000304	0.000905	CcSEcCtD
Acetylcysteine—Pruritus—Docetaxel—lung cancer	0.000301	0.000896	CcSEcCtD
Acetylcysteine—Nausea—Paclitaxel—lung cancer	0.000298	0.000887	CcSEcCtD
Acetylcysteine—Skin disorder—Methotrexate—lung cancer	0.000298	0.000886	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Methotrexate—lung cancer	0.000296	0.000882	CcSEcCtD
Acetylcysteine—Syncope—Doxorubicin—lung cancer	0.000292	0.000868	CcSEcCtD
Acetylcysteine—Hypotension—Methotrexate—lung cancer	0.000286	0.000853	CcSEcCtD
Acetylcysteine—Loss of consciousness—Doxorubicin—lung cancer	0.000286	0.000851	CcSEcCtD
Acetylcysteine—Cough—Doxorubicin—lung cancer	0.000284	0.000845	CcSEcCtD
Acetylcysteine—Dizziness—Docetaxel—lung cancer	0.000281	0.000837	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000275	0.000818	CcSEcCtD
Acetylcysteine—Dyspnoea—Methotrexate—lung cancer	0.000273	0.000813	CcSEcCtD
Acetylcysteine—Somnolence—Methotrexate—lung cancer	0.000273	0.000811	CcSEcCtD
Acetylcysteine—Vomiting—Docetaxel—lung cancer	0.00027	0.000805	CcSEcCtD
Acetylcysteine—Dyspepsia—Methotrexate—lung cancer	0.00027	0.000803	CcSEcCtD
Acetylcysteine—Rash—Docetaxel—lung cancer	0.000268	0.000798	CcSEcCtD
Acetylcysteine—Dermatitis—Docetaxel—lung cancer	0.000268	0.000797	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Doxorubicin—lung cancer	0.000265	0.00079	CcSEcCtD
Acetylcysteine—Oedema—Doxorubicin—lung cancer	0.000265	0.00079	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Methotrexate—lung cancer	0.000265	0.000788	CcSEcCtD
Acetylcysteine—Shock—Doxorubicin—lung cancer	0.000261	0.000777	CcSEcCtD
Acetylcysteine—Tachycardia—Doxorubicin—lung cancer	0.000259	0.000771	CcSEcCtD
Acetylcysteine—Skin disorder—Doxorubicin—lung cancer	0.000258	0.000767	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Doxorubicin—lung cancer	0.000257	0.000764	CcSEcCtD
Acetylcysteine—Nausea—Docetaxel—lung cancer	0.000253	0.000752	CcSEcCtD
Acetylcysteine—Hypotension—Doxorubicin—lung cancer	0.000248	0.000738	CcSEcCtD
Acetylcysteine—Urticaria—Methotrexate—lung cancer	0.000244	0.000725	CcSEcCtD
Acetylcysteine—Body temperature increased—Methotrexate—lung cancer	0.000242	0.000721	CcSEcCtD
Acetylcysteine—Dyspnoea—Doxorubicin—lung cancer	0.000237	0.000704	CcSEcCtD
Acetylcysteine—Somnolence—Doxorubicin—lung cancer	0.000236	0.000702	CcSEcCtD
Acetylcysteine—Dyspepsia—Doxorubicin—lung cancer	0.000234	0.000695	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000229	0.000682	CcSEcCtD
Acetylcysteine—Hypersensitivity—Methotrexate—lung cancer	0.000226	0.000672	CcSEcCtD
Acetylcysteine—Pruritus—Methotrexate—lung cancer	0.000217	0.000646	CcSEcCtD
Acetylcysteine—Urticaria—Doxorubicin—lung cancer	0.000211	0.000628	CcSEcCtD
Acetylcysteine—Body temperature increased—Doxorubicin—lung cancer	0.00021	0.000625	CcSEcCtD
Acetylcysteine—Dizziness—Methotrexate—lung cancer	0.000203	0.000603	CcSEcCtD
Acetylcysteine—Hypersensitivity—Doxorubicin—lung cancer	0.000196	0.000582	CcSEcCtD
Acetylcysteine—Vomiting—Methotrexate—lung cancer	0.000195	0.00058	CcSEcCtD
Acetylcysteine—Rash—Methotrexate—lung cancer	0.000193	0.000575	CcSEcCtD
Acetylcysteine—Dermatitis—Methotrexate—lung cancer	0.000193	0.000575	CcSEcCtD
Acetylcysteine—Pruritus—Doxorubicin—lung cancer	0.000188	0.000559	CcSEcCtD
Acetylcysteine—Nausea—Methotrexate—lung cancer	0.000182	0.000542	CcSEcCtD
Acetylcysteine—Dizziness—Doxorubicin—lung cancer	0.000176	0.000522	CcSEcCtD
Acetylcysteine—Vomiting—Doxorubicin—lung cancer	0.000169	0.000502	CcSEcCtD
Acetylcysteine—Rash—Doxorubicin—lung cancer	0.000167	0.000498	CcSEcCtD
Acetylcysteine—Dermatitis—Doxorubicin—lung cancer	0.000167	0.000498	CcSEcCtD
Acetylcysteine—Nausea—Doxorubicin—lung cancer	0.000158	0.000469	CcSEcCtD
Acetylcysteine—CHUK—Disease—HIF1A—lung cancer	2.1e-05	3.81e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—FGFR1—lung cancer	2.09e-05	3.8e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—AKT1—lung cancer	2.08e-05	3.79e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CDKN1A—lung cancer	2.07e-05	3.76e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—BCL2L1—lung cancer	2.07e-05	3.76e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PTEN—lung cancer	2.06e-05	3.75e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—STK11—lung cancer	2.05e-05	3.74e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—STK11—lung cancer	2.05e-05	3.73e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—JUNB—lung cancer	2.04e-05	3.72e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—NRAS—lung cancer	2.03e-05	3.69e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—SRC—lung cancer	2.02e-05	3.68e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—APOA1—lung cancer	2.02e-05	3.68e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KIT—lung cancer	2e-05	3.64e-05	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PIK3CA—lung cancer	1.99e-05	3.62e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CDKN1A—lung cancer	1.98e-05	3.61e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PTEN—lung cancer	1.98e-05	3.6e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EGF—lung cancer	1.98e-05	3.6e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FOXO3—lung cancer	1.98e-05	3.6e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—EP300—lung cancer	1.97e-05	3.58e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—NRAS—lung cancer	1.95e-05	3.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—MAPK3—lung cancer	1.94e-05	3.54e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.93e-05	3.51e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—SRC—lung cancer	1.91e-05	3.48e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GSTP1—lung cancer	1.9e-05	3.46e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CASP8—lung cancer	1.86e-05	3.39e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—STK11—lung cancer	1.86e-05	3.38e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL6R—lung cancer	1.86e-05	3.38e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CREBBP—lung cancer	1.85e-05	3.37e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AVP—lung cancer	1.85e-05	3.37e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CAT—lung cancer	1.85e-05	3.37e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—EGFR—lung cancer	1.85e-05	3.36e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—APC—lung cancer	1.85e-05	3.36e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KIT—lung cancer	1.85e-05	3.36e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDH1—lung cancer	1.84e-05	3.35e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—NRAS—lung cancer	1.84e-05	3.35e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.84e-05	3.35e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—SRC—lung cancer	1.84e-05	3.34e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EGF—lung cancer	1.82e-05	3.32e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KIT—lung cancer	1.81e-05	3.3e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ABCB1—lung cancer	1.8e-05	3.27e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EGF—lung cancer	1.79e-05	3.26e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FOXO3—lung cancer	1.79e-05	3.26e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IGF1R—lung cancer	1.78e-05	3.24e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—EGFR—lung cancer	1.77e-05	3.23e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MAP2K1—lung cancer	1.77e-05	3.22e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—TYMS—lung cancer	1.77e-05	3.22e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—NRAS—lung cancer	1.77e-05	3.21e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—MAPK3—lung cancer	1.76e-05	3.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CD—lung cancer	1.76e-05	3.2e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HES1—lung cancer	1.75e-05	3.19e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GSTM1—lung cancer	1.75e-05	3.18e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—KRAS—lung cancer	1.75e-05	3.18e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—BRAF—lung cancer	1.73e-05	3.16e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IL6R—lung cancer	1.71e-05	3.12e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CREBBP—lung cancer	1.71e-05	3.12e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CASP8—lung cancer	1.69e-05	3.07e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL6R—lung cancer	1.68e-05	3.06e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CREBBP—lung cancer	1.68e-05	3.06e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AVP—lung cancer	1.68e-05	3.06e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—KRAS—lung cancer	1.68e-05	3.05e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—EGFR—lung cancer	1.68e-05	3.05e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDH1—lung cancer	1.67e-05	3.04e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP1A1—lung cancer	1.66e-05	3.01e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ERCC2—lung cancer	1.64e-05	2.99e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MAP2K1—lung cancer	1.63e-05	2.97e-05	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—AKT1—lung cancer	1.63e-05	2.96e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CD—lung cancer	1.62e-05	2.95e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IGF1R—lung cancer	1.62e-05	2.94e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—EGFR—lung cancer	1.61e-05	2.93e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MAP2K1—lung cancer	1.6e-05	2.92e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PIK3CA—lung cancer	1.6e-05	2.92e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ERBB3—lung cancer	1.6e-05	2.91e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CD—lung cancer	1.59e-05	2.9e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HES1—lung cancer	1.59e-05	2.89e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—KRAS—lung cancer	1.58e-05	2.88e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MDM2—lung cancer	1.57e-05	2.87e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—RAF1—lung cancer	1.57e-05	2.86e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—ERBB2—lung cancer	1.55e-05	2.83e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PIK3CA—lung cancer	1.54e-05	2.8e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TERT—lung cancer	1.53e-05	2.79e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MTOR—lung cancer	1.53e-05	2.79e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CB—lung cancer	1.53e-05	2.79e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD4—lung cancer	1.53e-05	2.78e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KRAS—lung cancer	1.52e-05	2.77e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FGFR1—lung cancer	1.49e-05	2.71e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HRAS—lung cancer	1.48e-05	2.7e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HIF1A—lung cancer	1.47e-05	2.67e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PIK3CA—lung cancer	1.45e-05	2.65e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MDM2—lung cancer	1.45e-05	2.65e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ERBB3—lung cancer	1.45e-05	2.64e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—RAF1—lung cancer	1.45e-05	2.64e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ERBB2—lung cancer	1.43e-05	2.61e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MDM2—lung cancer	1.43e-05	2.6e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HRAS—lung cancer	1.42e-05	2.59e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—RAF1—lung cancer	1.42e-05	2.59e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—APOA1—lung cancer	1.42e-05	2.59e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—IL6—lung cancer	1.42e-05	2.58e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—APOA1—lung cancer	1.42e-05	2.58e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MTOR—lung cancer	1.41e-05	2.57e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CB—lung cancer	1.41e-05	2.57e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CD4—lung cancer	1.41e-05	2.57e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ERBB2—lung cancer	1.41e-05	2.56e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL2—lung cancer	1.41e-05	2.56e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KDR—lung cancer	1.4e-05	2.55e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTGS2—lung cancer	1.4e-05	2.55e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PIK3CA—lung cancer	1.4e-05	2.54e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TERT—lung cancer	1.39e-05	2.53e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MTOR—lung cancer	1.39e-05	2.53e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CB—lung cancer	1.39e-05	2.53e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD4—lung cancer	1.39e-05	2.52e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—JUN—lung cancer	1.37e-05	2.49e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.36e-05	2.48e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FGFR1—lung cancer	1.35e-05	2.46e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HRAS—lung cancer	1.35e-05	2.45e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HIF1A—lung cancer	1.33e-05	2.42e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDKN1A—lung cancer	1.33e-05	2.42e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PTEN—lung cancer	1.32e-05	2.41e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—AKT1—lung cancer	1.31e-05	2.38e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CG—lung cancer	1.3e-05	2.36e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—APC—lung cancer	1.29e-05	2.35e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KIT—lung cancer	1.29e-05	2.35e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CG—lung cancer	1.29e-05	2.35e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HRAS—lung cancer	1.29e-05	2.35e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—IL6—lung cancer	1.29e-05	2.34e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—APOA1—lung cancer	1.28e-05	2.34e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EGF—lung cancer	1.28e-05	2.33e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL2—lung cancer	1.28e-05	2.32e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KDR—lung cancer	1.27e-05	2.32e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EP300—lung cancer	1.26e-05	2.3e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—AKT1—lung cancer	1.26e-05	2.29e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—JUN—lung cancer	1.24e-05	2.26e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—POMC—lung cancer	1.23e-05	2.25e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—POMC—lung cancer	1.23e-05	2.24e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—SRC—lung cancer	1.23e-05	2.23e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CDKN1A—lung cancer	1.22e-05	2.23e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTEN—lung cancer	1.22e-05	2.23e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—BRAF—lung cancer	1.21e-05	2.21e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDKN1A—lung cancer	1.2e-05	2.19e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CREBBP—lung cancer	1.2e-05	2.19e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PTEN—lung cancer	1.2e-05	2.19e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL6R—lung cancer	1.2e-05	2.19e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CREBBP—lung cancer	1.2e-05	2.18e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—AKT1—lung cancer	1.19e-05	2.16e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—STAT3—lung cancer	1.18e-05	2.16e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—NRAS—lung cancer	1.18e-05	2.15e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CG—lung cancer	1.17e-05	2.13e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—APC—lung cancer	1.17e-05	2.13e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KIT—lung cancer	1.17e-05	2.13e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EP300—lung cancer	1.17e-05	2.12e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EGF—lung cancer	1.16e-05	2.11e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EP300—lung cancer	1.14e-05	2.08e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MAP2K1—lung cancer	1.14e-05	2.08e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—AKT1—lung cancer	1.14e-05	2.08e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CD—lung cancer	1.14e-05	2.08e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CD—lung cancer	1.14e-05	2.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SRC—lung cancer	1.13e-05	2.06e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MAPK3—lung cancer	1.13e-05	2.06e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ALB—lung cancer	1.13e-05	2.05e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—POMC—lung cancer	1.12e-05	2.03e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—SRC—lung cancer	1.11e-05	2.03e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—BRAF—lung cancer	1.1e-05	2.01e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—STAT3—lung cancer	1.09e-05	1.99e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NRAS—lung cancer	1.09e-05	1.99e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL6R—lung cancer	1.09e-05	1.98e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CREBBP—lung cancer	1.09e-05	1.98e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EGFR—lung cancer	1.08e-05	1.96e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—STAT3—lung cancer	1.07e-05	1.95e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—NRAS—lung cancer	1.07e-05	1.95e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MAPK3—lung cancer	1.04e-05	1.9e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MAP2K1—lung cancer	1.04e-05	1.89e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CD—lung cancer	1.03e-05	1.88e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MAPK3—lung cancer	1.03e-05	1.87e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MDM2—lung cancer	1.02e-05	1.85e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KRAS—lung cancer	1.02e-05	1.85e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MYC—lung cancer	1.02e-05	1.85e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—RAF1—lung cancer	1.01e-05	1.85e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ERBB2—lung cancer	1e-05	1.83e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CB—lung cancer	9.93e-06	1.81e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EGFR—lung cancer	9.93e-06	1.81e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MTOR—lung cancer	9.9e-06	1.8e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CB—lung cancer	9.9e-06	1.8e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTGS2—lung cancer	9.84e-06	1.79e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EGFR—lung cancer	9.76e-06	1.78e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CXCL8—lung cancer	9.52e-06	1.73e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KRAS—lung cancer	9.38e-06	1.71e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CA—lung cancer	9.34e-06	1.7e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MDM2—lung cancer	9.23e-06	1.68e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KRAS—lung cancer	9.22e-06	1.68e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—RAF1—lung cancer	9.2e-06	1.67e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CASP3—lung cancer	9.11e-06	1.66e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ERBB2—lung cancer	9.1e-06	1.66e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL2—lung cancer	9.1e-06	1.66e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CB—lung cancer	8.98e-06	1.64e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MTOR—lung cancer	8.98e-06	1.64e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCND1—lung cancer	8.87e-06	1.61e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—JUN—lung cancer	8.85e-06	1.61e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HRAS—lung cancer	8.64e-06	1.57e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CXCL8—lung cancer	8.63e-06	1.57e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CA—lung cancer	8.62e-06	1.57e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MMP9—lung cancer	8.61e-06	1.57e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTEN—lung cancer	8.58e-06	1.56e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CDKN1A—lung cancer	8.58e-06	1.56e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTEN—lung cancer	8.56e-06	1.56e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CA—lung cancer	8.47e-06	1.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL6—lung cancer	8.27e-06	1.51e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CASP3—lung cancer	8.26e-06	1.5e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL2—lung cancer	8.25e-06	1.5e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—EP300—lung cancer	8.19e-06	1.49e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EP300—lung cancer	8.16e-06	1.49e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCND1—lung cancer	8.04e-06	1.46e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—JUN—lung cancer	8.02e-06	1.46e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HRAS—lung cancer	7.98e-06	1.45e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SRC—lung cancer	7.94e-06	1.44e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HRAS—lung cancer	7.83e-06	1.43e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MMP9—lung cancer	7.81e-06	1.42e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDKN1A—lung cancer	7.78e-06	1.42e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTEN—lung cancer	7.76e-06	1.41e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VEGFA—lung cancer	7.73e-06	1.41e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—STAT3—lung cancer	7.65e-06	1.39e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NRAS—lung cancer	7.64e-06	1.39e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IL6—lung cancer	7.63e-06	1.39e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—AKT1—lung cancer	7.63e-06	1.39e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL6—lung cancer	7.5e-06	1.37e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EP300—lung cancer	7.4e-06	1.35e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MAPK3—lung cancer	7.31e-06	1.33e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SRC—lung cancer	7.2e-06	1.31e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MYC—lung cancer	7.11e-06	1.29e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—AKT1—lung cancer	7.04e-06	1.28e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VEGFA—lung cancer	7.01e-06	1.28e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EGFR—lung cancer	6.96e-06	1.27e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—STAT3—lung cancer	6.94e-06	1.26e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NRAS—lung cancer	6.92e-06	1.26e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AKT1—lung cancer	6.92e-06	1.26e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MAPK3—lung cancer	6.63e-06	1.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KRAS—lung cancer	6.57e-06	1.2e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MYC—lung cancer	6.45e-06	1.17e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EGFR—lung cancer	6.31e-06	1.15e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CA—lung cancer	6.06e-06	1.1e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CA—lung cancer	6.04e-06	1.1e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KRAS—lung cancer	5.96e-06	1.08e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TP53—lung cancer	5.84e-06	1.06e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HRAS—lung cancer	5.59e-06	1.02e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CA—lung cancer	5.47e-06	9.97e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL6—lung cancer	5.35e-06	9.73e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TP53—lung cancer	5.3e-06	9.64e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HRAS—lung cancer	5.06e-06	9.22e-06	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AKT1—lung cancer	4.95e-06	9.01e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKT1—lung cancer	4.93e-06	8.98e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL6—lung cancer	4.85e-06	8.83e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKT1—lung cancer	4.47e-06	8.14e-06	CbGpPWpGaD
